Related Experiment Video
Updated: Jan 25, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study
Zhi Yu1, Casey M Rebholz2, Eugenia Wong2
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD.
Hypertension accelerates kidney function decline over 30 years, especially in untreated individuals. Antihypertensive medications attenuated this decline, highlighting the importance of blood pressure management for kidney health.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Public Health
Background:
- Hypertension is a major risk factor for chronic kidney disease (CKD).
- The impact of hypertension and its treatment on kidney function decline over decades is not fully understood.
- Investigating the long-term effects of hypertension on estimated glomerular filtration rate (eGFR) is crucial for preventative strategies.
Purpose of the Study:
- To investigate the relationship between baseline hypertension status and the rate of change in estimated glomerular filtration rate (eGFR) over 30 years.
- To assess the influence of antihypertensive medication use on the association between hypertension and kidney function decline.
- To determine the 30-year predicted probabilities of developing CKD stage G3a+ across different hypertension categories.
Main Methods:
- Observational study utilizing data from 14,854 participants in the Atherosclerosis Risk in Communities (ARIC) Study.
- Baseline hypertension was categorized using 2017 ACC/AHA guidelines (normal BP, elevated BP, stage 1, stage 2 without medication, stage 2 with medication).
- Mixed-effects models analyzed the association between baseline hypertension and the slope of eGFR over 5 study visits across 30 years.
Main Results:
- Higher baseline blood pressure was associated with a faster annual eGFR decline compared to normal blood pressure.
- Individuals with stage 2 hypertension without medication showed the greatest eGFR decline (whites: -0.36 mL/min/1.73m²; African Americans: -0.50 mL/min/1.73m²).
- Predicted 30-year probabilities of developing CKD stage G3a+ were significantly higher in individuals with untreated stage 2 hypertension.
Conclusions:
- Baseline hypertension is linked to accelerated kidney function decline over 30 years in a general population.
- Antihypertensive medication use attenuated the rate of eGFR decline associated with hypertension.
- Effective blood pressure management is vital for preserving kidney function and preventing CKD progression.
More Related Videos
10:03Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Related Concept Videos
What are Populations and Communities?
Magnetic Declination
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Conservation of Declining Populations
Hypertension III: Clinical Manifestations and Diagnostic Studies
Imaging Studies I: Kidney, Ureter, and Bladder Studies